SCHEMBL1604154

SCHEMBL1604154

CCC1CCCC2CN(C(=O)CN3CCc4cc(Br)ccc4C3)CCN12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 2/20 0.41
ACACB O00763 1/20 0.38
XIAP P98170 1/20 0.38
BIRC2 Q13490 1/20 0.38
ALDH1A1 P00352 4/20 0.36
PKM P14618 2/20 0.36
GAA P10253 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
PRMT5 O14744 3/20 0.35
WDR77 Q9BQA1 1/20 0.35
ABHD6 Q9BV23 1/20 0.34
KDM4E B2RXH2 1/20 0.34
TSHR P16473 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12707109 1.00 CARM1 (0.41) CARM1ACACBXIAPBIRC2ALDH1A1
SCHEMBL1017280 0.89 XIAP (0.41) CARM1ACACBXIAPBIRC2ALDH1A1
SCHEMBL12707063 0.89 XIAP (0.41) CARM1ACACBXIAPBIRC2ALDH1A1
SCHEMBL12707114 0.88 KDM2B (0.38) ALDH1A1PKMGAAHSD17B10MEN1
SCHEMBL1018774 0.88 KDM2B (0.38) ALDH1A1PKMGAAHSD17B10MEN1
SCHEMBL1018350 0.84 PRMT5 (0.37) ACACBALDH1A1PKMGAAHSD17B10
SCHEMBL12707105 0.84 PRMT5 (0.37) ACACBALDH1A1PKMGAAHSD17B10
SCHEMBL12707120 0.82 KMT2A (0.42) ALDH1A1PKMGAAHSD17B10MEN1
SCHEMBL1020433 0.82 KMT2A (0.42) ALDH1A1PKMGAAHSD17B10MEN1
SCHEMBL1018279 0.82 TP53 (0.48) CARM1ACACBALDH1A1PKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 CARM1 1039/4885ACACB 3935/4885XIAP 4475/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 CARM1 1039/4885ACACB 3935/4885XIAP 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.